Literature DB >> 1497092

Ultrastructural immunohistochemical localization of polyclonal IgG, C3, and amyloid P component on the congo red-negative amyloid-like fibrils of fibrillary glomerulopathy.

G C Yang1, R Nieto, I Stachura, G R Gallo.   

Abstract

Renal biopsies from seven patients with Congo red-negative amyloid-like fibrillary glomerulopathy (FGP) were examined by protein A gold immuno-electron microscopy. Ultrastructurally, the fibrils in all cases exhibited positive immunostaining for IgG, both Ig light chains, C3, and amyloid P component (AP), but did not show positive immunostaining for glomerular basement membrane (GBM)-associated proteins (collagen type IV and heparan-sulfate proteoglycans) or microfibril-associated proteins (fibronectin and fibrillin). In a triple-label study, AP and IgG were colocalized along the same fibril, whereas the gold probes for the detection of collagen type IV were absent. The results suggest that the fibrils are comprised of polyclonal IgG and C3 that bind AP. AP was immunolocalized sparsely but regularly along the lamina rara interna of normal GBM. AP was absent in the fibrils in a case of diabetic glomerulopathy, was scattered randomly without specificity for the electron-dense deposits in the GBM of membranous glomerulopathy, and lined up regularly along the fibrils in amyloid deposits. FGP is an entity in which the fibrils bind AP but lack the beta-pleated sheet structure necessary for Congo red staining that is typical of amyloid.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1497092      PMCID: PMC1886617     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  40 in total

1.  Glomerulonephritis with organized deposits: a new clinicopathological entity? Light-, electron-microscopic and immunofluorescence study of 12 cases.

Authors:  G Mazzucco; S Casanova; U Donini; C Rollino; P Zucchelli; G Piccoli; G Monga
Journal:  Am J Nephrol       Date:  1990       Impact factor: 3.754

2.  The microfibrils of connective tissue: II. Immunohistochemical detection of the amyloid P component.

Authors:  S Inoué; C P Leblond; D S Grant; P Rico
Journal:  Am J Anat       Date:  1986-06

3.  Diabetic fibrillosis. A report of three cases.

Authors:  E Sohar; M Ravid; Y Ben-Shaul; T Reshef; J Gafni
Journal:  Am J Med       Date:  1970-07       Impact factor: 4.965

4.  Widespread occurrence of AP in amyloidotic tissues. An immunohistochemical observation.

Authors:  T Shirahama; M Skinner; J D Sipe; A S Cohen
Journal:  Virchows Arch B Cell Pathol Incl Mol Pathol       Date:  1985

5.  Association of fibronectin with the microfibrils of connective tissue.

Authors:  S Inoue; C P Leblond; P Rico; D Grant
Journal:  Am J Anat       Date:  1989-09

6.  Fibrillary glomerulonephritis: an entity with unusual immunofluorescence features.

Authors:  C E Alpers; H G Rennke; J Hopper; C G Biava
Journal:  Kidney Int       Date:  1987-03       Impact factor: 10.612

7.  The basement-membrane-like matrix of the mouse EHS tumor: III. Immunodetection of the amyloid P component in basotubules.

Authors:  S Inoue; C P Leblond
Journal:  Am J Anat       Date:  1985-12

8.  Fibrillary renal deposits and nephritis.

Authors:  J L Duffy; E Khurana; M Susin; G Gomez-Leon; J Churg
Journal:  Am J Pathol       Date:  1983-12       Impact factor: 4.307

9.  Glomerular permeability. I. Ferritin transfer across the normal glomerular capillary wall.

Authors:  M G FARQUHAR; S L WISSIG; G E PALADE
Journal:  J Exp Med       Date:  1961-01-01       Impact factor: 14.307

10.  Fibrillin, a new 350-kD glycoprotein, is a component of extracellular microfibrils.

Authors:  L Y Sakai; D R Keene; E Engvall
Journal:  J Cell Biol       Date:  1986-12       Impact factor: 10.539

View more
  15 in total

1.  Treatment of fibrillary glomerulonephritis by corticosteroids and tripterygium glycoside tablets: A case report.

Authors:  Zhao-Yu Lu; Hai-Feng Yang; Yu Peng; Yin Li; Zi-Chang Yin; Fu-Hua Lu; Xu-Sheng Liu
Journal:  Chin J Integr Med       Date:  2016-03-29       Impact factor: 1.978

2.  Glomerular Disease Pathology in the Era of Proteomics: From Pattern to Pathogenesis.

Authors:  Mark Haas
Journal:  J Am Soc Nephrol       Date:  2017-11-02       Impact factor: 10.121

3.  Fibrillary glomerulonephritis in a patient with systemic lupus erythematosus: a rare association.

Authors:  Zeenat Y Bhat; Xu Zeng; Jaideep Hingorani; Salman Khan; Madhumita Jena Mohanty
Journal:  Int Urol Nephrol       Date:  2011-11-19       Impact factor: 2.370

4.  Rare diagnosis in a patient with diabetes with nephrotic proteinuria.

Authors:  Ariana Azevedo; Patrícia Cotovio; Mário Góis; Fernando Nolasco
Journal:  BMJ Case Rep       Date:  2019-01-10

5.  DnaJ Homolog Subfamily B Member 9 Is a Putative Autoantigen in Fibrillary GN.

Authors:  Nicole K Andeen; Han-Yin Yang; Dao-Fu Dai; Michael J MacCoss; Kelly D Smith
Journal:  J Am Soc Nephrol       Date:  2017-11-02       Impact factor: 10.121

6.  Fibronectin non-amyloid glomerulopathy.

Authors:  Jim L Yong; Murray C Killingsworth; S Timothy Spicer; Xiao-Juan Wu
Journal:  Int J Clin Exp Pathol       Date:  2009-11-20

7.  Diagnosis of monoclonal immunotactoid glomerulopathy with positive λ chain by immunoelectron microscopy.

Authors:  Erina Sugita; Homare Sonoda; Masaki Ryuzaki; Akinori Hashiguchi; Hirobumi Tokuyama; Shu Wakino; Takeshi Kanda; Hiroshi Itoh
Journal:  CEN Case Rep       Date:  2022-06-14

8.  Light chain cardiomyopathy. Structural analysis of the light chain tissue deposits.

Authors:  G Gallo; F Goñi; F Boctor; R Vidal; A Kumar; F J Stevens; B Frangione; J Ghiso
Journal:  Am J Pathol       Date:  1996-05       Impact factor: 4.307

9.  Fibrillary glomerulonephritis and renal failure in a child with systemic lupus erythematosus.

Authors:  Shina Menon; Xu Zeng; Rudolph Valentini
Journal:  Pediatr Nephrol       Date:  2009-03-24       Impact factor: 3.714

10.  The occurrence or fibrillary glomerulonephritis in patients with diabetes mellitus may not be coincidental: a report of four cases.

Authors:  Fayna González-Cabrera; Fernando Henríquez-Palop; Ana Ramírez-Puga; Raquel Santana-Estupiñán; Celia Plaza-Toledano; Gloria Antón-Pérez; Silvia Marrero-Robayna; Davinia Ramírez-Medina; Roberto Gallego-Samper; Nicanor Vega-Díaz; Rafael Camacho-Galan; José C Rodríguez-Pérez
Journal:  Case Rep Med       Date:  2013-05-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.